Literature DB >> 18265409

Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens.

Agnieszka M Rygiel1, Francesca Milano, Febo J Ten Kate, John G de Groot, Maikel P Peppelenbosch, Jacques J G H M Bergman, Kauslillia K Krishnadath.   

Abstract

Abnormal DNA ploidy status has been suggested as a prognostic factor for Barrett's esophagus progression into esophageal adenocarcinoma (EAC). The aim of the study was to compare image cytometry DNA analysis (ICDA) and fluorescent in situ hybridization (FISH) in the assessment of DNA ploidy status in Barrett's esophagus (BE), and to determine the value of these abnormalities as an adjunct to conventional cytology in detection of dysplasia and EAC. Brush cytology specimens of 90 BE patients were examined using ICDA and FISH with peri-centromeric probes for chromosomes 7 and 17. The results of ICDA and FISH were compared with each other, and with dysplasia grade or EAC as determined by histology and cytology. FISH and ICDA detected abnormalities in 41% (37/90) and 22% (19/90) of the BE cases, respectively. Gains of chromosome 7 and/or 17 were present in 13% of nondysplasia cases, which further increased with dysplasia stage, while overall DNA content aneuploidy was detected predominantly in high grade dysplasia (HGD) and EAC. Using FISH results combined with cytology, we were able to identify IND/LGD (indefinite/ low grade dysplasia) with a sensitivity and specificity of 75 and 76%, respectively. FISH alone detected HGD/EAC with a high sensitivity and specificity of 85 and 84%, which was superior to that of cytology alone. Thus, FISH is more sensitive than ICDA to detect chromosomal abnormalities in BE brush cytology specimens. FISH detects chromosomal gains in early stages of BE and represents a valuable adjunct to conventional cytology to detect dysplasia or EAC. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18265409     DOI: 10.1002/gcc.20543

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  20 in total

Review 1.  Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms.

Authors:  Shelby D Melton; Robert M Genta; Rhonda F Souza
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

Review 2.  American Gastroenterological Association technical review on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

Review 3.  Biomarkers of Barrett's esophagus.

Authors:  Yasser Mahrous Fouad; Ibrahim Mostafa; Reem Yehia; Hisham El-Khayat
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 4.  Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Brian J Reid; Thomas G Paulson; Xiaohong Li
Journal:  Gastroenterology       Date:  2015-07-21       Impact factor: 22.682

5.  Biomarkers in Barrett's Esophagus.

Authors:  Rhonda F Souza
Journal:  Tech Gastrointest Endosc       Date:  2010-04

6.  Predicting Neoplastic Progression in Barrett's Esophagus.

Authors:  Jean S Wang; Marcia I Canto
Journal:  Ann Gastroentol Hepatol       Date:  2010-06

Review 7.  Predictive biomarkers for Barrett's esophagus: so near and yet so far.

Authors:  M R Timmer; G Sun; E C Gorospe; C L Leggett; L Lutzke; K K Krishnadath; K K Wang
Journal:  Dis Esophagus       Date:  2013-01-14       Impact factor: 3.429

8.  Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity.

Authors:  Heather D Kissel; Patricia C Galipeau; Xiaohong Li; Brian J Reid
Journal:  Cancer Biomark       Date:  2009       Impact factor: 4.388

9.  The molecular basis of carcinogenesis in Barrett's esophagus.

Authors:  Rhonda F Souza
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

10.  Barrett's esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments.

Authors:  Cassie L Booth; Kevin S Thompson
Journal:  J Gastrointest Oncol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.